Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CES1 | P23141 | 4/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2125465 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL10964046 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL10960913 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL10960947 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL10959885 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL2126868 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL10960790 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL2126603 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL2126029 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 | |
| SCHEMBL10962978 | 0.98 | NAAA (0.56) | NAAAMEN1KMT2ATDP1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| EP-3552252-B1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-3552252-B1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| US-11005042-B2 | Formulations containing ketones comprising non-aromatic cycles | MERCK PATENT GMBH (DE) | 2021-05-11 | — | — | US | disclosed |
| US-10892414-B2 | Process for making electronic device | MERCK PATENT GMBH (DE) | 2021-01-12 | — | — | US | disclosed |
| US-20200066990-A1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2020-02-27 | — | — | US | disclosed |
| EP-3552252-A1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | Merck Patent GmbH (DE) | 2019-10-16 | — | — | EP | disclosed |
| US-9815759-B2 | Processes for producing phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-11-14 | — | — | US | disclosed |
| WO-2017097391-A1 | FORMULATIONS CONTAINING KETONES COMPRISING NON-AROMATIC CYCLES | MERCK PATENT GMBH (DE) | 2017-06-15 | — | — | WO | disclosed |
| EP-3031792-A1 | PROCESSES FOR PRODUCING PHENOL | ExxonMobil Chemical Patents Inc. (US) | 2016-06-15 | — | — | EP | disclosed |
| US-20130225866-A1 | Processes for Producing Phenol | ExxonMobil Chemical Company - Law Technology (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130217921-A1 | \"PROCESSES FOR PRODUCING PHENOL\ | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-08-22 | — | — | US | disclosed |
| US-20130217922-A1 | Processes for Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-08-22 | — | — | US | disclosed |
| US-20130211157-A1 | Cyclohexylbenzene Compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-08-15 | — | — | US | disclosed |
| US-20130204045-A1 | \"CYCLOHEXANONE COMPOSITIONS\ | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-08-08 | — | — | US | disclosed |
| EP-2616426-A1 | CYCLOHEXANONE COMPOSITIONS | ExxonMobil Chemical Patents Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013052216-A1 | PROCESS FOR PRODUCING PHENOL FROM CYCLOHEXYLBENZENE HYDROPEROXIDE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| US-20120108851-A1 | METHOD FOR PRODUCING NORBORNENE DERIVATIVE | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| EP-2444386-A1 | PROCESS FOR PREPARATION OF NORBORNENE DERIVATIVES | JX Nippon Oil & Energy Corporation (JP) | 2012-04-25 | — | — | EP | disclosed |
| WO-2012036818-A1 | CYCLOHEXANONE COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225866-A1 | Processes for Producing Phenol | CYP1A1, CYP2E1, HPD | NAAA 2690/4885L3MBTL1 3687/4885MEN1 4716/4885 |
| US-20130211157-A1 | Cyclohexylbenzene Compositions | CYP1B1, CYP1A1, CYP2E1 | NAAA 3997/4885L3MBTL1 2217/4885MEN1 4840/4885 |
| US-20130217921-A1 | \"PROCESSES FOR PRODUCING PHENOL\ | CYP1A1, CYP2E1, PAH | NAAA 2528/4885L3MBTL1 3108/4885MEN1 4688/4885 |
| US-20130217922-A1 | Processes for Producing Phenol | HPD, PAH, AOX1 | NAAA 1853/4885L3MBTL1 3808/4885MEN1 4814/4885 |
| US-20130204045-A1 | \"CYCLOHEXANONE COMPOSITIONS\ | CYP2J2, CYP2W1, CYP8B1 | NAAA 4229/4885L3MBTL1 4320/4885MEN1 3605/4885 |
| US-20120108851-A1 | METHOD FOR PRODUCING NORBORNENE DERIVATIVE | UGT1A8, UGT8, ALG8 | NAAA 890/4885L3MBTL1 4751/4885MEN1 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.